AMBER REAMS: Open Payments
NPI 1790378859 · HERMITAGE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 13 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $60 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $23 |
| Corcept Therapeutics | 1 | $23 |
| Cycle Pharmaceuticals Inc | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| EMD Serono, Inc. | 1 | $19 |
| TerSera Therapeutics LLC | 1 | $19 |
Products named: ENJAYMO, WAYRILZ, AYVAKIT, ICLUSIG, KEYTRUDA, NERLYNX, Korlym, Phyrago.
Industry payments across TN — which companies pay providers there.
